Hetero is one of India's leading generic pharmaceutical companies with more than 20 years of expertise in the pharmaceutical industry. Hetero has more than 25 state-of-the-art manufacturing facilities approved by stringent regulatory authorities like US FDA, EU, TGA-Australia, MCC-South Africa and others. Hetero's portfolio includes more than 200 products, Hetero has a strong global presence in over 120 countries and focusses on making affordable medicines accessible to patients worldwide.
A Leading Group with global presence and approvals from MHRA-UK, EU-GMR ANVISA Brazil. PIC/S Ukraine. WHO Geneva. INVIMA Columbia. USFDA*- 2018 conducting Walk-in Interview for multiple positions at different locations. Exposure of working with Regulatory Approved facilities will be desired.
Envision Scientific Pvt. Ltd. is a leading provider of drug delivery technologies to the healthcare industry. Our developed technologies are designed to be utilized for various types of drug and different delivery systems. Its proprietary NANO ACTIVETM Technology is designed for drug delivery utilizing Nanotechnology from various types of devices and surfaces. We Vision ‘To have a Happy and Healthy World’.
ALEOR Dermaceuticals Ltd, is a joint venture of "Alembic and Orbicular" to develop and commercialize dermatology products for global markets, requires suitable candidates for its Dermaceuticals formulation manufacturing facility at Karakhadi, Padra, Vadodara, Gujarat.
Post : Quality Control - Quality Assurance Production - Packaging
Bajaj Healthcare Ltd. is a company established in 1993, services various Pharmaceuticals, Nutraceutical and Food industries globally with a spirit of scrupulousness. Bajaj Healthcare Ltd.
Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country. Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.
Ipca is a fully integrated, rapidly growing Indian pharmaceutical company with a strong thrust on exports. Ipca's APIs and Formulations produced at worldclass manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA). With operations in over 100 countries, exports account for over 52% of the company's income.